Synaptic Vulnerability in Neurodegenerative Disease

Abstract Recent developments in our understanding of the pathophysiological mechanisms underlying degeneration in both the central and peripheral nervous systems have highlighted the critical role that synapses play in the instigation and progression of neuronal loss. In fact, several lines of evidence suggest that previous attempts to delay the onset and progression of clinical symptoms in a broad range of neurodegenerative diseases may have been unsuccessful as a result of a failure to protect synaptic compartments. As a result, the synapse needs to be viewed as an important target for the development of novel protective treatments aimed at preventing or slowing disease progression. We summarize important findings from human studies and animal models demonstrating common synaptic vulnerability across several neurodegenerative diseases. We also discuss recent developments in our understanding of degenerative mechanisms that are known to be localized to synapses and suggest potential ways to harness this understanding to develop synaptoprotective strategies for neurodegenerative disease.

[1]  M. Mattson,et al.  p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults , 2007, NeuroMolecular Medicine.

[2]  G. Arbuthnott,et al.  Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion. , 2006, Brain : a journal of neurology.

[3]  J. Geddes,et al.  Synaptic Mitochondria Are More Susceptible to Ca2+Overload than Nonsynaptic Mitochondria* , 2006, Journal of Biological Chemistry.

[4]  Kevin A. Robertson,et al.  The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells. , 2006, Human molecular genetics.

[5]  Pico Caroni,et al.  Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF , 2006, Nature Neuroscience.

[6]  R. Ribchester,et al.  The neuroprotective Wld S gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells , 2006 .

[7]  J. Harris,et al.  Envenoming bites by kraits: the biological basis of treatment-resistant neuromuscular paralysis. , 2005, Brain : a journal of neurology.

[8]  Thomas C. Südhof,et al.  α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.

[9]  Xinran Liu,et al.  Progressively reduced synaptic vesicle pool size in cultured neurons derived from neuronal ceroid lipofuscinosis-1 knockout mice , 2005, Neurobiology of Disease.

[10]  M. Coleman Axon degeneration mechanisms: commonality amid diversity , 2005, Nature Reviews Neuroscience.

[11]  E. Masliah,et al.  β-Amyloid Immunotherapy Prevents Synaptic Degeneration in a Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[12]  R. Balice-Gordon,et al.  Neuromuscular synaptogenesis in wild-type and mutant zebrafish. , 2005, Developmental biology.

[13]  Raymond A. Dwek,et al.  Storage solutions: treating lysosomal disorders of the brain , 2005, Nature Reviews Neuroscience.

[14]  Michael D. Ehlers,et al.  Ubiquitin and Protein Turnover in Synapse Function , 2005, Neuron.

[15]  A. Singleton Altered α-synuclein homeostasis causing Parkinson's disease: the potential roles of dardarin , 2005, Trends in Neurosciences.

[16]  Marc Vidal,et al.  Systematic analysis of genes required for synapse structure and function , 2005, Nature.

[17]  C. Culmsee,et al.  p53 in neuronal apoptosis. , 2005, Biochemical and biophysical research communications.

[18]  Stanley I. Rapoport Le fonctionnement synaptique évalué par l’imagerie fonctionnelle du cerveau dans la maladie d’Alzheimer , 2005 .

[19]  H. Willison The immunobiology of Guillain‐Barré syndromes , 2005, Journal of the peripheral nervous system : JPNS.

[20]  Timothy H Murphy,et al.  Rapid Reversible Changes in Dendritic Spine Structure In Vivo Gated by the Degree of Ischemia , 2005, The Journal of Neuroscience.

[21]  R. Fetter,et al.  Presynaptic Spectrin Is Essential for Synapse Stabilization , 2005, Current Biology.

[22]  W. K. Cullen,et al.  Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo , 2005, Nature Medicine.

[23]  R. Ribchester,et al.  Progressive loss of motor neuron function in wasted mice: effects of a spontaneous null mutation in the gene for the eEF1 A2 translation factor. , 2005, Journal of neuropathology and experimental neurology.

[24]  S. Cheema,et al.  Loss of synaptophysin‐positive boutons on lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H transgenic mouse model of ALS , 2005, Journal of neuroscience research.

[25]  A. Musarò,et al.  Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model , 2005, The Journal of cell biology.

[26]  B. Ghetti,et al.  Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Jun Xie,et al.  RNAi knockdown of Par‐4 inhibits neurosynaptic degeneration in ALS‐linked mice , 2005, Journal of neurochemistry.

[28]  Hitoshi Osaka,et al.  The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. , 2004, Brain : a journal of neurology.

[29]  E. Masliah,et al.  Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  W. K. Cullen,et al.  Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. , 2005, Nature medicine.

[31]  T. Südhof,et al.  Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. , 2005, Cell.

[32]  A. Singleton Altered alpha-synuclein homeostasis causing Parkinson's disease: the potential roles of dardarin. , 2005, Trends in neurosciences.

[33]  S. Rapoport [In vivo imaging for evaluating synaptic integrity in Alzheimer disease]. , 2005, Psychologie & neuropsychiatrie du vieillissement.

[34]  Christoph Schmitz,et al.  Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS , 2005, Nature Neuroscience.

[35]  Thomas H Gillingwater,et al.  Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation , 2004, The European journal of neuroscience.

[36]  Roger Kurlan,et al.  A focus on the synapse for neuroprotection in Alzheimer disease and other dementias , 2004, Neurology.

[37]  J. Kordower,et al.  Early changes in Huntington’s disease patient brains involve alterations in cytoskeletal and synaptic elements , 2004, Journal of neurocytology.

[38]  S. Ohara,et al.  Axonal dystrophy of dorsal root ganglion sensory neurons in a mouse model of Niemann–Pick disease type C , 2004, Experimental Neurology.

[39]  Coleman Mp,et al.  Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system. , 2004 .

[40]  Structural dynamics of synapses in living animals , 2004, Current Opinion in Neurobiology.

[41]  T. Südhof,et al.  The Synaptic Vesicle Protein CSPα Prevents Presynaptic Degeneration , 2004, Neuron.

[42]  R. Ribchester,et al.  Axotomy‐dependent and ‐independent synapse elimination in organ cultures of Wlds mutant mouse skeletal muscle , 2004, Journal of neuroscience research.

[43]  G. Cole,et al.  Rapid annexin-V labeling in synaptosomes , 2004, Neurochemistry International.

[44]  J. Glass,et al.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man , 2004, Experimental Neurology.

[45]  R. Ribchester,et al.  Neuroprotection after Transient Global Cerebral Ischemia in Wlds Mutant Mice , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  T. Südhof,et al.  The synaptic vesicle protein CSP alpha prevents presynaptic degeneration. , 2004, Neuron.

[47]  S. Maruyama,et al.  Synapse loss in anterior horn neurons in amyotrophic lateral sclerosis , 2004, Acta Neuropathologica.

[48]  R. Ribchester,et al.  Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system. , 2004, Current drug targets. CNS and neurological disorders.

[49]  J. Sundsfjord,et al.  123I-β-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia , 2004, Psychopharmacology.

[50]  S. Scheff,et al.  Synaptic pathology in Alzheimer’s disease: a review of ultrastructural studies , 2003, Neurobiology of Aging.

[51]  V. Sossi,et al.  [11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease. , 2003, Brain : a journal of neurology.

[52]  Christian Haass,et al.  Games Played by Rogue Proteins in Prion Disorders and Alzheimer's Disease , 2003, Science.

[53]  Patrik Brundin,et al.  Huntington's disease: a synaptopathy? , 2003, Trends in molecular medicine.

[54]  J. Melki,et al.  Riluzole attenuates spinal muscular atrophy disease progression in a mouse model , 2003, Muscle & nerve.

[55]  F. Gage,et al.  Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model , 2003, Science.

[56]  K. Davies,et al.  Neuromuscular defects in a Drosophila survival motor neuron gene mutant. , 2003, Human molecular genetics.

[57]  R. Ribchester,et al.  The relationship of neuromuscular synapse elimination to synaptic degeneration and pathology: Insights from WldS and other mutant mice , 2003, Journal of neurocytology.

[58]  J. Melki,et al.  Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy. , 2003, Human molecular genetics.

[59]  V. Perry,et al.  Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease , 2003, The European journal of neuroscience.

[60]  D. Mitter,et al.  The synaptophysin/synaptobrevin interaction critically depends on the cholesterol content , 2002, Journal of neurochemistry.

[61]  V. Sossi,et al.  DTBZ-PET correlates of levodopa responses in asymmetric Parkinson ' s disease , 2003 .

[62]  K. Svoboda,et al.  Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex , 2002, Nature.

[63]  C. Fletcher,et al.  Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease , 2002, Nature Genetics.

[64]  D. Selkoe Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[65]  D. Tagle,et al.  PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains. , 2002, Human molecular genetics.

[66]  R. Ribchester,et al.  Age‐Dependent Synapse Withdrawal at Axotomised Neuromuscular Junctions in Wlds Mutant and Ube4b/Nmnat Transgenic Mice , 2002, The Journal of physiology.

[67]  H. Mizukami,et al.  Neuroprotective Effects of Glial Cell Line-Derived Neurotrophic Factor Mediated by an Adeno-Associated Virus Vector in a Transgenic Animal Model of Amyotrophic Lateral Sclerosis , 2002, The Journal of Neuroscience.

[68]  H. Uylings,et al.  Neuronal Changes in Normal Human Aging and Alzheimer's Disease , 2002, Brain and Cognition.

[69]  J. Melki,et al.  Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model. , 2002, Human molecular genetics.

[70]  D. Muller,et al.  Remodeling of Hippocampal Synaptic Networks by a Brief Anoxia–Hypoglycemia , 2002, The Journal of Neuroscience.

[71]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[72]  I. Akiguchi,et al.  Differential expression between synaptic vesicle proteins and presynaptic plasma membrane proteins in the anterior horn of amyotrophic lateral sclerosis , 2002, Acta Neuropathologica.

[73]  M. Chesselet,et al.  Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. , 2001, Journal of neurophysiology.

[74]  M. Lehtovirta,et al.  CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. , 2001, Human molecular genetics.

[75]  E. Bigio,et al.  Contribution of asymmetric synapse loss to lateralizing clinical deficits in frontotemporal dementias. , 2001, Archives of neurology.

[76]  R. Ribchester,et al.  Compartmental neurodegeneration and synaptic plasticity in the Wlds mutant mouse , 2001, The Journal of physiology.

[77]  Y. Maruyama,et al.  Changes in presynaptic proteins, SNAP-25 and synaptophysin, in the hippocampal CA1 area in ischemic gerbils , 2001, Brain Research.

[78]  Paolo Guidetti,et al.  Early Degenerative Changes in Transgenic Mice Expressing Mutant Huntingtin Involve Dendritic Abnormalities but No Impairment of Mitochondrial Energy Production , 2001, Experimental Neurology.

[79]  E. Masliah,et al.  Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease , 2001, Neurology.

[80]  M. Lehtovirta,et al.  Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL). , 2001, Human molecular genetics.

[81]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[82]  M. Pinter,et al.  Functional motor unit failure precedes neuromuscular degeneration in canine motor neuron disease , 2000, Annals of neurology.

[83]  M. Mattson Apoptotic and Anti‐Apoptotic Synaptic Signaling Mechanisms , 2000, Brain pathology.

[84]  P. Caroni,et al.  Early and Selective Loss of Neuromuscular Synapse Subtypes with Low Sprouting Competence in Motoneuron Diseases , 2000, The Journal of Neuroscience.

[85]  A. Johnston,et al.  Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie‐infected murine hippocampus , 2000, Neuropathology and applied neurobiology.

[86]  M. Haltia,et al.  Human prion diseases , 2000, Annals of medicine.

[87]  M. Mattson,et al.  Caspase and calpain substrates: Roles in synaptic plasticity and cell death , 1999, Journal of neuroscience research.

[88]  Gary Lynch,et al.  Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice , 1999, Brain Research.

[89]  R. Motter,et al.  Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.

[90]  J. Mcculloch,et al.  Drug development for stroke: importance of protecting cerebral white matter. , 1999, European journal of pharmacology.

[91]  M. Iwata,et al.  Ultrastructural change of synapses of Betz cells in patients with amyotrophic lateral sclerosis , 1999, Neuroscience Letters.

[92]  M. Mattson,et al.  Prostate Apoptosis Response‐4 Production in Synaptic Compartments Following Apoptotic and Excitotoxic Insults , 1999, Journal of neurochemistry.

[93]  T. Bliss,et al.  Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice , 1999, Nature Neuroscience.

[94]  R. Brady,et al.  Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[95]  E. Bigio,et al.  Neocortical Synapse Density and Braak Stage in the Lewy Body Variant of Alzheimer Disease: A Comparison with Classic Alzheimer Disease and Normal Aging , 1998, Journal of neuropathology and experimental neurology.

[96]  M. Mattson,et al.  Evidence for Synaptic Apoptosis , 1998, Experimental Neurology.

[97]  B. Miller,et al.  Frontotemporal dementia: Neuropil spheroids and presynaptic terminal degeneration , 1998, Annals of neurology.

[98]  S. Hirai,et al.  Loss of Cholinergic Synapses on the Spinal Motor Neurons of Amyotrophic Lateral Sclerosis , 1998, Journal of neuropathology and experimental neurology.

[99]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[100]  S. DeArmond,et al.  Workshop 4: Human Prion Diseases , 1994 .

[101]  S. Prusiner,et al.  Human prion diseases , 1994, Annals of neurology.

[102]  D. Richman,et al.  Neuromuscular transmission in amyotrophic lateral sclerosis , 1993, Muscle & nerve.

[103]  M. Royston,et al.  Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study. , 1993, Neuroreport.

[104]  R. Shin,et al.  Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. , 1992, The American journal of pathology.

[105]  N W Kowall,et al.  Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[106]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[107]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[108]  D. Mann,et al.  A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease , 1987, Journal of the Neurological Sciences.

[109]  G. Graveland,et al.  Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. , 1985, Science.